Construction of hyaluronic acid noisome as functional transdermal nanocarrier for tumor therapy

Ming Kong, Hyun Jin Park, Chao Feng, Lin Hou, Xiaojie Cheng, Xiguang Chen

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

To develop a functional nanosized transdermal drug delivery system for tumor therapy, amphiphilic hyaluronic acid (HA) based niosome was constructed combining transdermal and tumor targeting ability in one entity. HA esterified with monostearin, the conjugate labeled as HA-GMS self-Assembled onto niosome surface and formed HA-niosome. The multilayer vesicle had small size (around 40 nm), good stability and desirable drug encapsulating efficacy, and well compatible with blood. It exhibited better endocytosis to mouse breast tumor cell (4T1) than the control chitosan nanoparticle, which was verified qualitatively and quantitatively. Skin permeation of HA-niosome was proven to be efficient using in vitro stratum corneum model and in vivo fluorescence observation. Histological section study confirmed the security and efficiency of transdermal permeation. The results evidence HA-niosome to be exciting and promising for tumor therapy through trandermal administration.

Original languageEnglish
Pages (from-to)634-641
Number of pages8
JournalCarbohydrate Polymers
Volume94
Issue number1
DOIs
Publication statusPublished - 2013 Apr 15

Fingerprint

Hyaluronic acid
Hyaluronic Acid
Tumors
Liposomes
Permeation
Chitosan
Skin
Multilayers
Blood
Fluorescence
Cells
Nanoparticles
Pharmaceutical Preparations

Keywords

  • Hyaluronic acid
  • Niosome
  • Transdermal
  • Tumor therapy

ASJC Scopus subject areas

  • Organic Chemistry
  • Materials Chemistry
  • Polymers and Plastics

Cite this

Construction of hyaluronic acid noisome as functional transdermal nanocarrier for tumor therapy. / Kong, Ming; Park, Hyun Jin; Feng, Chao; Hou, Lin; Cheng, Xiaojie; Chen, Xiguang.

In: Carbohydrate Polymers, Vol. 94, No. 1, 15.04.2013, p. 634-641.

Research output: Contribution to journalArticle

Kong, Ming ; Park, Hyun Jin ; Feng, Chao ; Hou, Lin ; Cheng, Xiaojie ; Chen, Xiguang. / Construction of hyaluronic acid noisome as functional transdermal nanocarrier for tumor therapy. In: Carbohydrate Polymers. 2013 ; Vol. 94, No. 1. pp. 634-641.
@article{fb2c9ef3433f414082716e140ac01841,
title = "Construction of hyaluronic acid noisome as functional transdermal nanocarrier for tumor therapy",
abstract = "To develop a functional nanosized transdermal drug delivery system for tumor therapy, amphiphilic hyaluronic acid (HA) based niosome was constructed combining transdermal and tumor targeting ability in one entity. HA esterified with monostearin, the conjugate labeled as HA-GMS self-Assembled onto niosome surface and formed HA-niosome. The multilayer vesicle had small size (around 40 nm), good stability and desirable drug encapsulating efficacy, and well compatible with blood. It exhibited better endocytosis to mouse breast tumor cell (4T1) than the control chitosan nanoparticle, which was verified qualitatively and quantitatively. Skin permeation of HA-niosome was proven to be efficient using in vitro stratum corneum model and in vivo fluorescence observation. Histological section study confirmed the security and efficiency of transdermal permeation. The results evidence HA-niosome to be exciting and promising for tumor therapy through trandermal administration.",
keywords = "Hyaluronic acid, Niosome, Transdermal, Tumor therapy",
author = "Ming Kong and Park, {Hyun Jin} and Chao Feng and Lin Hou and Xiaojie Cheng and Xiguang Chen",
year = "2013",
month = "4",
day = "15",
doi = "10.1016/j.carbpol.2013.01.091",
language = "English",
volume = "94",
pages = "634--641",
journal = "Carbohydrate Polymers",
issn = "0144-8617",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Construction of hyaluronic acid noisome as functional transdermal nanocarrier for tumor therapy

AU - Kong, Ming

AU - Park, Hyun Jin

AU - Feng, Chao

AU - Hou, Lin

AU - Cheng, Xiaojie

AU - Chen, Xiguang

PY - 2013/4/15

Y1 - 2013/4/15

N2 - To develop a functional nanosized transdermal drug delivery system for tumor therapy, amphiphilic hyaluronic acid (HA) based niosome was constructed combining transdermal and tumor targeting ability in one entity. HA esterified with monostearin, the conjugate labeled as HA-GMS self-Assembled onto niosome surface and formed HA-niosome. The multilayer vesicle had small size (around 40 nm), good stability and desirable drug encapsulating efficacy, and well compatible with blood. It exhibited better endocytosis to mouse breast tumor cell (4T1) than the control chitosan nanoparticle, which was verified qualitatively and quantitatively. Skin permeation of HA-niosome was proven to be efficient using in vitro stratum corneum model and in vivo fluorescence observation. Histological section study confirmed the security and efficiency of transdermal permeation. The results evidence HA-niosome to be exciting and promising for tumor therapy through trandermal administration.

AB - To develop a functional nanosized transdermal drug delivery system for tumor therapy, amphiphilic hyaluronic acid (HA) based niosome was constructed combining transdermal and tumor targeting ability in one entity. HA esterified with monostearin, the conjugate labeled as HA-GMS self-Assembled onto niosome surface and formed HA-niosome. The multilayer vesicle had small size (around 40 nm), good stability and desirable drug encapsulating efficacy, and well compatible with blood. It exhibited better endocytosis to mouse breast tumor cell (4T1) than the control chitosan nanoparticle, which was verified qualitatively and quantitatively. Skin permeation of HA-niosome was proven to be efficient using in vitro stratum corneum model and in vivo fluorescence observation. Histological section study confirmed the security and efficiency of transdermal permeation. The results evidence HA-niosome to be exciting and promising for tumor therapy through trandermal administration.

KW - Hyaluronic acid

KW - Niosome

KW - Transdermal

KW - Tumor therapy

UR - http://www.scopus.com/inward/record.url?scp=84874397949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874397949&partnerID=8YFLogxK

U2 - 10.1016/j.carbpol.2013.01.091

DO - 10.1016/j.carbpol.2013.01.091

M3 - Article

C2 - 23544584

AN - SCOPUS:84874397949

VL - 94

SP - 634

EP - 641

JO - Carbohydrate Polymers

JF - Carbohydrate Polymers

SN - 0144-8617

IS - 1

ER -